Bromotiacumicin compounds
    1.
    发明授权
    Bromotiacumicin compounds 失效
    溴菊酯化合物

    公开(公告)号:US5767096A

    公开(公告)日:1998-06-16

    申请号:US678906

    申请日:1996-07-12

    CPC分类号: C07H17/08

    摘要: Antimicrobial compounds having the formula ##STR1## wherein R.sup.1 and R.sup.2 are independently selected from the group consisting of hydrogen and C.sub.1 -to-C.sub.4 alkanoyl; R.sup.3 and R.sup.4 are selected from the group consisting of (a) R.sup.3 is hydrogen and R.sup.4 is hydroxy, (b) R.sup.3 is hydroxy and R.sup.4 is hydrogen, (c) R.sup.3 and R.sup.4 taken together are .dbd.O; or selected from the group consisting of hydrogen and hydroxy; and R.sup.5 and R.sup.6 are independently selected from the group consisting of hydrogen, bromine and chlorine, with the proviso that at least one of R.sup.5 and R.sup.6 must be bromine. Also disclosed are pharmaceutical compositions comprising such compounds, methods of treating bacterial infection by the administration thereof and a process for preparing said compounds.

    摘要翻译: 具有式“IMAGE”的抗微生物化合物,其中R 1和R 2独立地选自氢和C 1 -C 4烷酰基; R3和R4选自(a)R3是氢,R4是羟基,(b)R3是羟基,R4是氢,(c)R3和R4一起是= O; 或选自氢和羟基; 并且R 5和R 6独立地选自氢,溴和氯,条件是R 5和R 6中的至少一个必须是溴。 还公开了包含这些化合物的药物组合物,通过其给药治疗细菌感染的方法和制备所述化合物的方法。

    Antifungal compounds
    8.
    发明授权
    Antifungal compounds 失效
    抗真菌化合物

    公开(公告)号:US5356933A

    公开(公告)日:1994-10-18

    申请号:US84335

    申请日:1993-06-28

    摘要: Novel compounds having the structural formula ##STR1## and pharmaceutically acceptable salts and prodrugs thereof, wherein one of R.sup.1 and R.sup.2 is hydrogen and the other is --CH.dbd.CHCOOH, X is >CH--, and Y is --0--; or, alternatively, the bond between X and Y is not present, X is --CH.sub.2 --, and Y is --OH, as well as methods for their use, pharmaceutical compositions containing the same, and a process for their preparation via fermentation.

    摘要翻译: 具有结构式“IMAGE”的新型化合物及其药学上可接受的盐和前药,其中R1和R2之一是氢,另一个是-CH = CHCOOH,X是> CH-,Y是-O-。 或者,X和Y之间的键不存在,X是-CH 2 - ,Y是-OH,以及它们的使用方法,含有它们的药物组合物,以及通过发酵制备的方法。